Randomized phase III study comparing an early PET driven treatment de-escalation to a not PET-monitored strategy in patients with advanced stages Hodgkin lymphoma: Final analysis of the AHL2011 LYSA study

Authors :: Veronique Edeline
Pierre Feugier
Nicolas Mounier
Kamal Bouabdallah
Marc André
Bertrand Joly
Alexandra Traverse-Glehen
Reda Bouabdallah
Oumedaly Reman
Gilles Salles
Franck Morschhauser
Olivier Casasnovas
Emmanuelle Nicolas-Virelizier
Alina Berriolo-Riedinger
Pauline Brice
Richard Delarue
Michel Meignan
Jehan Dupuis
Aspasia Stamatoulas
Thomas Gastinne
Source :: Journal of Clinical Oncology. 36:7503-7503
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 7503Background: Escalated BEACOPP (BEA) improves PFS but not OS in pts with advanced HL compared to ABVD and is associated to a higher risk of hematological toxicity, secondary leukemia and inferti...

Tools